Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia
- PMID: 7679571
Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia
Abstract
The primary objective of this study was to ascertain the effectiveness of granulocyte colony-stimulating factor in the treatment of antithyroid drug-induced granulocytopenia of varying degree. Sixteen patients with Graves' disease with antithyroid drug-induced granulocytopenia (granulocyte counts < 1.0 x 10(9)/L) each received a daily dose of 75 micrograms of granulocyte colony-stimulating factor administered subcutaneously. Within 24 hours of the first injection, the granulocyte count increased (0.6 to 12.3 x 10(9)/L) in all 10 patients with mild granulocytopenia (granulocyte counts between 0.5 and 1.0 x 10(9)/L) and all three with moderate granulocytopenia (granulocyte counts < 0.5 x 10(9)/L). The three remaining patients with severe granulocytopenia (agranulocytic), whose granulocyte counts were zero, did not recover from granulocytopenia until the 6th, 7th, and 14th days of treatment with granulocyte colony-stimulating factor. Examination of bone marrow taken at the onset of the disease in all three agranulocytic patients showed a prominent decrease in granulocytic series, while identical examination in six of eight patients with mild to moderate granulocytopenia showed close to normal granulocytic series. There was no elevation of serum granulocyte colony-stimulating factor concentration in four patients with mild granulocytopenia and one with moderate granulocytopenia at the onset of their disease, whereas those of the remaining three patients with severe granulocytopenia (agranulocytic) increased at onset of agranulocytosis. This information led us to conclude that: (1) granulocyte colony-stimulating factor is effective in the treatment of antithyroid drug-induced mild to moderate granulocytopenia and (2) in severe agranulocytic cases, granulocyte colony-stimulating factor is not effective. Accordingly, we were again reminded of the importance of early diagnosis and treatment of antithyroid drug-induced agranulocytosis.
Similar articles
-
Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia.Thyroid. 1997 Aug;7(4):575-8. doi: 10.1089/thy.1997.7.575. Thyroid. 1997. PMID: 9292945
-
[Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998 Jun;20(3):226-9. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998. PMID: 11367711 Chinese.
-
[Granulocyte colony-stimulating factor treatment (G-CSF) of antithyroid drug-induced granulocytopenia: granulocyte count measurement after 4 hours of G-CSF injection is useful for the detection of recovery from granulocytopenia].Nihon Naibunpi Gakkai Zasshi. 1994 Jun 20;70(5):517-20. doi: 10.1507/endocrine1927.70.5_517. Nihon Naibunpi Gakkai Zasshi. 1994. PMID: 7525366 Clinical Trial. Japanese.
-
Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere.Thyroid. 1999 Oct;9(10):1033-5. doi: 10.1089/thy.1999.9.1033. Thyroid. 1999. PMID: 10560960 Review.
-
Resolution of drug-induced agranulocytosis.Geriatrics. 2000 Feb;55(2):89-91. Geriatrics. 2000. PMID: 10711310 Review. No abstract available.
Cited by
-
Methimazole associated neutropenia in a preterm neonate treated for hyperthyroidism.Case Rep Endocrinol. 2015;2015:680191. doi: 10.1155/2015/680191. Epub 2015 Feb 24. Case Rep Endocrinol. 2015. PMID: 25810932 Free PMC article.
-
Risks of rhG-CSF treatment in drug-induced agranulocytosis.Ann Hematol. 1995 Mar;70(3):143-7. doi: 10.1007/BF01682034. Ann Hematol. 1995. PMID: 7536476
-
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management.Drugs R D. 2017 Mar;17(1):91-96. doi: 10.1007/s40268-017-0172-1. Drugs R D. 2017. PMID: 28105610 Free PMC article. Review.
-
Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics.Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):214-8. doi: 10.1007/s12288-015-0595-1. Epub 2015 Sep 22. Indian J Hematol Blood Transfus. 2016. PMID: 27408395 Free PMC article.
-
Massive plasmacytosis with severe marrow suppression induced by methimazole in Graves' disease patients: case report and literature review.Int J Clin Exp Med. 2014 Oct 15;7(10):3605-8. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25419407 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources